In the media: Genomeweb: Partial reimbursement for comprehensive DNA test in the Netherlands

This week, Genomeweb’s Precision Oncology News brought the news that the Dutch House of Representatives has recently unanimously decided to reimburse the comprehensive DNA testing for certain patient groups.

Read the article.

More information about the comprehensive DNA test.

You read an article in the category Billing code. You may also be interested in OncoAct.
All news

Also read

Whole genome sequencing is reliable, has added value, and can be embedded perfectly into everyday pathology diagnostics

Whole genome sequencing is reliable, has added value, and can be embedded perfectly into everyday pathology diagnostics

10-08-2022

Source: website Netherlands Cancer Institute With the rapidly expanding tableau of (increasingly tumor-agnostic) targeted therapies, genome-driven cancer care has become …

Whole genome sequencing to improve individual cancer treatment in Finland

Whole genome sequencing to improve individual cancer treatment in Finland

10-07-2020

Since August 2019, Docrates, a private cancer center in Finland, uses the whole genome sequencing test from Hartwig Medical Foundation to …

Growth Fund invests 325 million euros in Oncode-PACT to accelerate the development of cancer drugs

Growth Fund invests 325 million euros in Oncode-PACT to accelerate the development of cancer drugs

14-04-2022

The National Growth Fund invests 325 million euros in the Oncode-PACT plan to accelerate the preclinical development process of cancer …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl